Researchers at Uppsala University showed for the first time that CAR T cells can transfer CAR molecules to T cells. But it may not necessarily translate to better outcomes against a tumor, Stefano Barbera told Allison Whitten. Read more about the work here: https://bit.ly/3XHfmNN
Drug Discovery News
图书期刊出版业
Wilmington ，Delaware 8,143 位关注者
Exploring drug discovery and development
关于我们
Drug Discovery News provides engaging stories about scientific breakthroughs that will help life science researchers develop diagnostic and therapeutic approaches for improving human health. Read the latest drug development news at drugdiscoverynews.com.
- 网站
-
https://drugdiscoverynews.com/
Drug Discovery News的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 11-50 人
- 总部
- Wilmington ，Delaware
- 类型
- 私人持股
- 创立
- 2005
- 领域
- drug discovery and development、life science research、pharmaceuticals、biotechnology、publishing、clinical trials、biopharmaceuticals、diagnostics、biomarkers、cancer research、journalism、translational research和preclinical research
地点
-
主要
获取路线
1000 N West Street, Suite 1200
US，Delaware，Wilmington ，19801
Drug Discovery News员工
-
Rajesh Kumar
News Editor/ Reporter at DDNews
-
Hannah Thomasy
Fellowship in Global Journalism at Dalla Lana School of Public Health, University of Toronto
-
Nidhi kumar
Celebrity show host on Indias public broadcaster at DD NEWS and DD NATIONAL, Ministry of Science, and Technology, Media lead and ambassador at Mitron…
-
Vikas pal singh
Asstt.Producer at DD NEWS
动态
-
Lipid nanoparticles (LNPs) have emerged as popular vehicles for delivering various types of drugs. But they can interact with the human body, potentially causing damage to the recipient’s genetic material. In this webinar, Shambhu Roy. will discuss how to test the genotoxicity of LNP-based therapeutics to ensure the safety of these innovative drug delivery systems. Register now: https://bit.ly/3EVkwPz
-
-
Postpartum depression prevalence is high and on the rise. Researchers found that neuroactive steroid levels in the third trimester may predict postpartum depression, which could be used as potential biomarkers for early diagnosis and intervention before symptoms develop. Read more: https://bit.ly/3D3hhoH
-
-
A metabolite produced by gut bacteria may control sugar intake by working through the liver to trigger the release of brain-acting hormones. The discovery could lead to new approaches for managing type 2 diabetes. Read more: https://bit.ly/43dszBk
-
-
“Women decide not to have children because of this disease,” Jessica Ailani of MedStar Georgetown University Hospital told Allison Whitten. Read this new story to find out why specialists like Ailani are excited about a new migraine drug in clinical trials from Lundbeck: https://bit.ly/3ERYcpZ
-
-
??Join our team! LabX Media Group is looking for a Paid Ads Specialist to join our Marketing team, supporting DDN and other brands within LMG! Do you have experience running paid advertising campaigns across platforms such as Facebook, LinkedIn, and Google Ads? Learn more about the role, here: https://bit.ly/3Xe2dLM
-
-
With its unique formulation as a fusion protein, Amgen's dazodalibep has a better safety profile than other drugs that have targeted the CD40 ligand. Sumita Bhatta and her team at Amgen are now enrolling Sj?gren’s disease patients in Phase 3 trials for this drug. Read more: https://bit.ly/417a7HV
-
-
Researchers identified a strain of E. coli linked to Crohn’s disease that produces a compound that triggers intestinal scarring, revealing a potential treatment path. Read more: https://bit.ly/3QnoFyj
-
-
New phenotypic methods can help identify the best antibiotic to treat sepsis, urinary tract infections, and other bacterial infections. Read more: https://bit.ly/4hYRUD8
-
-
Drug design is entering a new era. Join Milan Mrksich for a Q&A about megamolecules — large, intricate protein-based structures — and their diagnostic and therapeutic potential for various health conditions. Save your spot now: https://bit.ly/416S2K8
-